Recently, it was found that verrucarin A induces ROS levels in breast cancer MDA-MB-231 cells resulting in the activation of p38-MAPK and the inhibition of EGFR/Akt/ERK signaling cascade to cause cell deaths [18]. The gene discussed is EGFR; the disease is breast cancer.